Ameriprise’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$385K Sell
155,792
-32,102
-17% -$67.9K ﹤0.01% 3679
2025
Q4
$385K Sell
187,894
-250
-0.1% -$722 ﹤0.01% 3721
2025
Q3
$653K Buy
+188,144
New +$525K ﹤0.01% 3534
2025
Q1
Sell
-227,609
Closed -$289K 4055
2024
Q4
$289K Buy
227,609
+168,134
+283% +$428K ﹤0.01% 3740
2024
Q3
$203K Buy
59,475
+21,766
+58% +$94.8K ﹤0.01% 3749
2024
Q2
$176K Buy
37,709
+5,933
+19% +$33.5K ﹤0.01% 3707
2024
Q1
$236K Sell
31,776
-6,694
-17% -$55.6K ﹤0.01% 3649
2023
Q4
$390K Buy
38,470
+25,254
+191% +$222K ﹤0.01% 3539
2023
Q3
$103K Sell
13,216
-6,034
-31% -$51.7K ﹤0.01% 3795
2023
Q2
$158K Sell
19,250
-39,240
-67% -$342K ﹤0.01% 3762
2023
Q1
$424K Sell
58,490
-135,769
-70% -$1.21M ﹤0.01% 3488
2022
Q4
$1.72M Sell
194,259
-6,275
-3% -$68.9K ﹤0.01% 2875
2022
Q3
$2.45M Buy
200,534
+154,906
+339% +$2.41M ﹤0.01% 2690
2022
Q2
$539K Sell
45,628
-1,588
-3% -$21.3K ﹤0.01% 3369
2022
Q1
$898K Sell
47,216
-5,297
-10% -$98.5K ﹤0.01% 3257
2021
Q4
$1.4M Buy
52,513
+17,144
+48% +$590K ﹤0.01% 3104
2021
Q3
$1.45M Sell
35,369
-13,862
-28% -$760K ﹤0.01% 2994
2021
Q2
$2.79M Buy
49,231
+12,249
+33% +$452K ﹤0.01% 2770
2021
Q1
$1.55M Buy
36,982
+11,639
+46% +$663K ﹤0.01% 2948
2020
Q4
$1.67M Buy
25,343
+14,294
+129% +$587K ﹤0.01% 2872
2020
Q3
$309K Sell
11,049
-3,010
-21% -$98K ﹤0.01% 3415
2020
Q2
$414K Sell
14,059
-8,322
-37% -$217K ﹤0.01% 3254
2020
Q1
$444K Sell
22,381
-29,626
-57% -$747K ﹤0.01% 3170
2019
Q4
$1.54M Sell
52,007
-19,109
-27% -$477K ﹤0.01% 2862
2019
Q3
$1.62M Buy
71,116
+17,522
+33% +$434K ﹤0.01% 2800
2019
Q2
$1.33M Sell
53,594
-11,114
-17% -$265K ﹤0.01% 2947
2019
Q1
$1.58M Buy
64,708
+15,865
+32% +$359K ﹤0.01% 2851
2018
Q4
$1.11M Sell
48,843
-5,827
-11% -$159K ﹤0.01% 2900
2018
Q3
$1.74M Buy
54,670
+21,097
+63% +$682K ﹤0.01% 2863
2018
Q2
$1.2M Buy
33,573
+13,769
+70% +$488K ﹤0.01% 2949
2018
Q1
$580K Buy
+19,804
New +$706K ﹤0.01% 3165

Other funds holding EDIT